Clinical Trial: Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662655) titled 'Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study' on May 02.

Brief Summary: this study aims to investigate the efficacy and safety of PADN therapy compared with standard medical therapy in patients diagnosed with pulmonary hypertension after M-TEER, thereby providing evidence for clinical treatment decision-making

Study Start Date: June 06

Study Type: INTERVENTIONAL

Condition: Pulmonary Hypertension Pulmonary Hypertension Associated With HFpEF

Intervention: DEVICE: Percutaneous Pulmonary Artery ...